EWS Antibodies

Santa Cruz Biotechnology features a diverse variety of EWS Antibodies for advanced research in molecular biology. EWS Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EWS, or Ewing sarcoma breakpoint region 1, plays a critical role in RNA processing and transcription regulation. EWS is particularly significant in Ewing sarcoma, a type of cancer that primarily affects children and young adults, where chromosomal translocations lead to oncogenic fusion proteins. Understanding EWS function and interactions advances the development of targeted therapies and cancer research. Researchers can detect and analyze EWS expression patterns across various cell types and tissues. Multiple conjugation options are available, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), enabling versatile experimental approaches. Santa Cruz Biotechnology monoclonal antibodies for EWS support researchers worldwide in their mission to unlock new insights in cancer biology and therapeutic development.